Status:
COMPLETED
Botulinum Toxin Type A in Diabetic Peripheral Neuropathy
Lead Sponsor:
Alexandria University
Conditions:
Diabetic Neuropathies
Eligibility:
All Genders
Phase:
PHASE4
Brief Summary
Background: Diabetes mellitus is commonly complicated by diabetic peripheral neuropathy. Due to common side effects and poor tolerance to medication, poor adherence to medication is common in diabetic...
Detailed Description
This study is a comparative study on 30 patients with type 2 diabetes mellitus proved by nerve conduction study on carbamazepine. Patients were divided randomly into 3 groups. First group was add on ...
Eligibility Criteria
Inclusion
- diabetic patients type 2 were included on single line of treatment with carbamazepine
Exclusion
- any sever medical condition that might interfere with the results.
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 8 2022
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT05296759
Start Date
February 1 2021
End Date
March 8 2022
Last Update
April 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
faculty of medicine Alexandria university
Alexandria, Egypt